title: Primary cutaneous large B-cell lymphoma, leg type, successfully treated with rituximab plus chemotherapy.
authors.forename: Celia
authors.initials: C
authors.lastname: Posada García
authors.forename: Angeles
authors.initials: A
authors.lastname: Florez
authors.forename: Raquel
authors.initials: R
authors.lastname: Pardavila
authors.forename: Arancha
authors.initials: A
authors.lastname: Garcia-Cruz
authors.forename: Lourders
authors.initials: L
authors.lastname: Amador
authors.forename: Mónica
authors.initials: M
authors.lastname: Alvarez
authors.forename: Laura María
authors.initials: LM
authors.lastname: Alberte
authors.forename: Manuel José
authors.initials: MJ
authors.lastname: Cruces
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide; D004317:Doxorubicin; D005260:Female; D006801:Humans; D007866:Leg; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008942:Mitoxantrone; D011239:Prednisolone; D011241:Prednisone; D000069283:Rituximab; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014750:Vincristine
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D008942:Mitoxantrone; D011241:Prednisone